{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T21:57:00Z","timestamp":1795298220506,"version":"4.10.3"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["R01AI139261"],"award-info":[{"award-number":["R01AI139261"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaerobe"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.anaerobe.2026.103072","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:08:34Z","timestamp":1786115314000},"page":"103072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Microbiome Stewardship: re-defining high-risk antibiotics"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6645-406X","authenticated-orcid":false,"given":"Taryn","family":"Eubank","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1582-0611","authenticated-orcid":false,"given":"Abdulwhab Shremo","family":"Msdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2063-7503","authenticated-orcid":false,"given":"Kevin W.","family":"Garey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.anaerobe.2026.103072_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00417-24","article-title":"Public health case for microbiome-sparing antibiotics and new opportunities for drug development","volume":"9","author":"McDonald","year":"2024","journal-title":"mSphere"},{"issue":"5","key":"10.1016\/j.anaerobe.2026.103072_bib2","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: mechanistic insights","volume":"71","author":"de Vos","year":"2022","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.anaerobe.2026.103072_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00502-24","article-title":"Commensal resilience: ancient ecological lessons for the modern microbiota","volume":"93","author":"Rose","year":"2025","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.anaerobe.2026.103072_bib4","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41575-022-00610-0","article-title":"Capturing the environment of the Clostridioides difficile infection cycle","volume":"19","author":"Schnizlein","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.anaerobe.2026.103072_bib5","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41467-025-66888-1","article-title":"Meta-analysis of 22,710 human microbiome metagenomes defines an oral-to-gut microbial enrichment score and associations with host health and disease","volume":"17","author":"Manghi","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.anaerobe.2026.103072_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00007-19","article-title":"Gut Microbiota and colonization resistance against bacterial enteric infection","volume":"83","author":"Ducarmon","year":"2019","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"6","key":"10.1016\/j.anaerobe.2026.103072_bib7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1473-3099(22)00811-8","article-title":"Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysis","volume":"23","author":"Willems","year":"2023","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.anaerobe.2026.103072_bib8","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1038\/s41467-019-13467-w","article-title":"Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection","volume":"10","author":"Magruder","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.anaerobe.2026.103072_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2157200","article-title":"Differential response to prolonged amoxicillin treatment: long-term resilience of the microbiome versus long-lasting perturbations in the gut resistome","volume":"15","author":"Dhariwal","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.anaerobe.2026.103072_bib10","article-title":"The impact of antibiotic exposure on antibiotic resistance gene dynamics in the gut microbiota of inflammatory bowel disease patients","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Microbiol."},{"issue":"20","key":"10.1016\/j.anaerobe.2026.103072_bib11","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa2002606","article-title":"Macrolide and nonmacrolide resistance with mass azithromycin distribution","volume":"383","author":"Doan","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.anaerobe.2026.103072_bib12","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/jac\/dkl420","article-title":"Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes","volume":"58","author":"Lofmark","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"issue":"15","key":"10.1016\/j.anaerobe.2026.103072_bib13","article-title":"Prebiotics improve blood pressure control by modulating gut microbiome composition and function: a systematic review and meta-analysis","volume":"17","author":"Shremo","year":"2025","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.anaerobe.2026.103072_bib14","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.cell.2012.01.035","article-title":"The impact of the gut microbiota on human health: an integrative view","volume":"148","author":"Clemente","year":"2012","journal-title":"Cell"},{"issue":"6469","key":"10.1016\/j.anaerobe.2026.103072_bib15","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.aax3760","article-title":"Lactose drives Enterococcus expansion to promote graft-versus-host disease","volume":"366","author":"Stein-Thoeringer","year":"2019","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.anaerobe.2026.103072_bib16","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jhep.2013.11.034","article-title":"Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity","volume":"60","author":"Vrieze","year":"2014","journal-title":"J. Hepatol."},{"issue":"700","key":"10.1016\/j.anaerobe.2026.103072_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq4006","article-title":"Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis","volume":"15","author":"Halsey","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.anaerobe.2026.103072_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/nu17050825","article-title":"Microbiome-based therapeutics for salt-sensitive hypertension: a scoping review","volume":"17","author":"Shremo Msdi","year":"2025","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.anaerobe.2026.103072_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s40168-020-00875-0","article-title":"Microbiome definition re-visited: old concepts and new challenges","volume":"8","author":"Berg","year":"2020","journal-title":"Microbiome"},{"issue":"5","key":"10.1016\/j.anaerobe.2026.103072_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00062-25","article-title":"The case for microbiome stewardship: what it is and how to get there","volume":"10","author":"Choudoir","year":"2025","journal-title":"mSystems"},{"issue":"1","key":"10.1016\/j.anaerobe.2026.103072_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlz015","article-title":"Rethinking antimicrobial stewardship paradigms in the context of the gut microbiome","volume":"1","author":"Shahi","year":"2019","journal-title":"JAC Antimicrob Resist"},{"issue":"8","key":"10.1016\/j.anaerobe.2026.103072_bib22","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1128\/AAC.00670-13","article-title":"Antibiotic administration routes significantly influence the levels of antibiotic resistance in gut microbiota","volume":"57","author":"Zhang","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.anaerobe.2026.103072_bib23","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/jac\/dkaf278","article-title":"Faecal pharmacokinetics, microbiome, and bile acid changes in healthy subjects given intravenous followed by oral omadacycline; a Phase 1 clinical trial","volume":"80","author":"Jo","year":"2025","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.anaerobe.2026.103072_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/mbo3.1260","article-title":"Impact of antibiotics on the human microbiome and consequences for host health","volume":"11","author":"Patangia","year":"2022","journal-title":"Microbiologyopen"},{"issue":"5","key":"10.1016\/j.anaerobe.2026.103072_bib25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1365-2125.2005.02357.x","article-title":"Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males","volume":"59","author":"Stass","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.anaerobe.2026.103072_bib26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa2106516","article-title":"SER-109, an oral microbiome therapy for recurrent Clostridioides difficile infection","volume":"386","author":"Feuerstadt","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.anaerobe.2026.103072_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2327442","article-title":"Long- and short-term effects of fecal microbiota transplantation on antibiotic resistance genes: results from a randomized placebo-controlled trial","volume":"16","author":"Rashidi","year":"2024","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.anaerobe.2026.103072_bib28","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.53570","article-title":"Assessment of quality of life among patients with recurrent Clostridioides difficile infection treated with investigational oral microbiome therapeutic SER-109: secondary analysis of a randomized clinical trial","volume":"6","author":"Garey","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.anaerobe.2026.103072_bib29","article-title":"Fecal microbiota transplantation-current perspective on human health","volume":"12","author":"Cao","year":"2025","journal-title":"Front. Med."},{"issue":"12","key":"10.1016\/j.anaerobe.2026.103072_bib30","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1093\/jac\/dkaa364","article-title":"A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome effects of ibezapolstat administered orally to healthy subjects","volume":"75","author":"Garey","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"issue":"8","key":"10.1016\/j.anaerobe.2026.103072_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02244-21","article-title":"Functional and metagenomic evaluation of Ibezapolstat for early evaluation of anti-recurrence effects in Clostridioides difficile infection","volume":"66","author":"McPherson","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.anaerobe.2026.103072_bib32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"7","key":"10.1016\/j.anaerobe.2026.103072_bib33","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/cid\/ciac096","article-title":"Efficacy, safety, pharmacokinetics, and microbiome changes of ibezapolstat in adults with Clostridioides difficile infection: a phase 2a multicenter clinical trial","volume":"75","author":"Garey","year":"2022","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.anaerobe.2026.103072_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2025.101126","article-title":"Efficacy, safety, pharmacokinetics, and associated microbiome changes of ibezapolstat compared with vancomycin in adults with Clostridioides difficile infection: a phase 2b, randomised, double-blind, active-controlled, multicentre study","volume":"6","author":"Eubank","year":"2025","journal-title":"Lancet Microbe"},{"issue":"3","key":"10.1016\/j.anaerobe.2026.103072_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1473-3099(18)30614-5","article-title":"Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials","volume":"19","author":"Gerding","year":"2019","journal-title":"Lancet Infect. Dis."},{"issue":"12","key":"10.1016\/j.anaerobe.2026.103072_bib36","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1093\/jac\/dkx299","article-title":"Surotomycin versus vancomycin in adults with Clostridium difficile infection: primary clinical outcomes from the second pivotal, randomized, double-blind, phase 3 trial","volume":"72","author":"Daley","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.anaerobe.2026.103072_bib37","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijantimicag.2015.02.027","article-title":"Ecological effect of ceftazidime\/avibactam on the normal human intestinal microbiota","volume":"46","author":"Rashid","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"8016","key":"10.1016\/j.anaerobe.2026.103072_bib38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-024-07502-0","article-title":"A gram-negative-selective antibiotic that spares the gut microbiome","volume":"630","author":"Munoz","year":"2024","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.anaerobe.2026.103072_bib39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ajic.2023.09.007","article-title":"Impact of doxycycline on Clostridioides difficile infection in patients hospitalized with community-acquired pneumonia","volume":"52","author":"O'Leary","year":"2024","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.anaerobe.2026.103072_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2025.108322","article-title":"Threshold effects of doxycycline postexposure prophylaxis (PEP) on the gut resistome and microbiome: evidence from change-point analyses","volume":"163","author":"Manoharan-Basil","year":"2026","journal-title":"Int. J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.anaerobe.2026.103072_bib41","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1056\/NEJMoa1800170","article-title":"Omadacycline for acute bacterial skin and skin-structure infections","volume":"380","author":"O'Riordan","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.anaerobe.2026.103072_bib42","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa1800201","article-title":"Omadacycline for community-acquired bacterial pneumonia","volume":"380","author":"Stets","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.anaerobe.2026.103072_bib43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/infdis\/jiad537","article-title":"Fecal pharmacokinetics and gut microbiome effects of oral omadacycline versus vancomycin in healthy volunteers","volume":"229","author":"Jo","year":"2024","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.anaerobe.2026.103072_bib44","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41579-023-00936-9","article-title":"Antibiotic-induced collateral damage to the microbiota and associated infections","volume":"21","author":"de Nies","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"7","key":"10.1016\/j.anaerobe.2026.103072_bib45","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jamainternmed.2024.0581","article-title":"Mortality of patients with sepsis administered piperacillin-tazobactam vs cefepime","volume":"184","author":"Chanderraj","year":"2024","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"10.1016\/j.anaerobe.2026.103072_bib46","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2333748","article-title":"The effects of antibiotic exposures on the gut resistome during hematopoietic cell transplantation in children","volume":"16","author":"Heston","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.anaerobe.2026.103072_bib47","doi-asserted-by":"crossref","DOI":"10.1039\/D5MD00591D","article-title":"How to spare gut microbiota from antibiotic effects? PK-PD based innovative strategies, target specificity, and molecule-to-medicinal properties","author":"Rai","year":"2025","journal-title":"RSC Med. Chem."},{"issue":"1","key":"10.1016\/j.anaerobe.2026.103072_bib48","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1038\/s41467-024-52373-8","article-title":"The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy volunteers","volume":"15","author":"Messaoudene","year":"2024","journal-title":"Nat. Commun."}],"container-title":["Anaerobe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996426000521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996426000521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:56:34Z","timestamp":1789606594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1075996426000521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"alternative-id":["S1075996426000521"],"URL":"https:\/\/doi.org\/10.1016\/j.anaerobe.2026.103072","relation":{},"ISSN":["1075-9964"],"issn-type":[{"value":"1075-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiome Stewardship: re-defining high-risk antibiotics","name":"articletitle","label":"Article Title"},{"value":"Anaerobe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anaerobe.2026.103072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103072"}}